Cover Image
市場調查報告書

全球結膜炎市場:2015年∼2019年

Global Conjunctivitis Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 350461
出版日期 內容資訊 英文 72 Pages
訂單完成後即時交付
價格
Back to Top
全球結膜炎市場:2015年∼2019年 Global Conjunctivitis Market 2015-2019
出版日期: 2016年01月20日 內容資訊: 英文 72 Pages
簡介

結膜炎是由於過敏,細菌,病毒等造成眼結膜的感染或發炎。過敏原有煙,花粉,扁虱,眼科用藥,化妝品,香水等…皆有可能成為結膜炎的原因。全球結膜炎市場預測在2015年∼2019年這段期間,年複合成長率將為1.94%。

本報告提供全球結膜炎市場相關調查分析,為您彙整產業概要,地區市場概要,推動市場的要素,市場課題,市場趨勢,主要供應商等資訊。

第1章 摘要整理

第2章 報告的範圍

第3章 市場調查的方法

  • 調查方法
  • 經濟指標

第4章 簡介

第5章 結膜炎概要

  • 結膜炎的種類
  • 徵兆與症狀
  • 診斷

第6章 開發平台分析

第7章 市場的狀況

  • 市場概要
  • 市場規模與預測
  • 美國的結膜炎藥市場
  • 美國的細菌性結膜炎藥市場
  • 美國的病毒性結膜炎藥市場
  • 美國的過敏性結膜炎藥市場
  • 波特的五力分析

第8章 市場區隔:狀態別

  • 細菌性結膜炎藥
  • 病毒性結膜炎藥
  • 過敏性結膜炎藥
  • 全球結膜炎藥市場
  • 全球病毒性結膜炎藥市場
  • 全球過敏性結膜炎藥市場

第9章 各地區市場區隔

  • 全球結膜炎藥市場各地區市場區隔
  • 南北美洲
  • 歐洲/中東/非洲
  • 亞太地區

第10章 推動市場的要素

  • 與化學物質和污染物質的接觸增加
  • 病情受到高度關注
  • 病毒性結膜炎治療的開發
  • 開發平台藥物的暫定核准

第11章 促進要素的影響

第12章 市場課題

第13章 促進要素與課題的影響

第14章 市場趨勢

第15章 供應商狀況

第16章 主要供應商分析

第17章 附錄

第18章 Technavio的其他報告

另紙一覽

目錄
Product Code: IRTNTR7542

About Conjunctivitis

Conjunctivitis, also called pink eye or Madras eye, is an infection in or inflammation of the conjunctiva. It affects either one or both a person's eyes and can be the result of an allergy, bacteria, or a virus. Allergens such as smoke, pollen, dust mites, eye drops, cosmetics, and perfumes can lead to conjunctivitis. It is usually associated with redness of the eye along with the release of mucoid discharges. Although the condition usually heals without medication, antibiotics are commonly used for treatment to avoid complications due to irritation of the eye.

Technavio's analysts forecast the global conjunctivitis medication market to grow at a CAGR of 1.94% during the period 2015-2019.

Covered in this report

The report covers the present scenario and the growth prospects of the global conjunctivitis medication market for 2015-2019. To calculate the market size, the report considers revenue generated from the sale of various prescription medication along with the over-the-counter (OTC) medication used to treat bacterial, viral, and allergic conjunctivitis.

The market is divided into the following segments based on geography:

  • APAC
  • EMEA
  • Americas

Technavio's report, Global Conjunctivitis Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Akorn
  • Alcon
  • Allergan
  • Bausch & Lomb

Other Prominent Vendors

  • Celsus Therapeutics
  • Eleven Biotherapeutics
  • Griffin Discoveries
  • InSite Vision
  • Merck
  • Nicox
  • NovaBay
  • Ocular Therapeutix
  • Santen Pharmaceutical
  • Shire (Foresight Biotherapeutics)
  • Starpharma
  • Sun Pharmaceutical

Market driver

  • Increased exposure to chemicals and pollutants
  • For a full, detailed list, view our report

Market challenge

  • Patent expiry of medication
  • For a full, detailed list, view our report

Market trend

  • Strategic alliances and M&A
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Overview: Conjunctivitis

  • Types of conjunctivitis
  • Signs and symptoms
  • Diagnosis

PART 06: Pipeline analysis

  • AC-170
  • AGN-229666
  • DEXTENZA
  • SUN-1334H
  • Auriclosene
  • EBI-005
  • FST-100
  • SPL7013
  • OPX-1
  • AzaSite Xtra (ISV-405)
  • GD134

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Conjunctivitis medication market in the US
  • Bacterial conjunctivitis medication market in the US
  • Viral conjunctivitis medication market in the US
  • Allergic conjunctivitis medication market in the US
  • Five forces analysis

PART 08: Market segmentation based on condition type

  • Bacterial conjunctivitis medication
  • Viral conjunctivitis medication
  • Allergic conjunctivitis medication
  • Global bacterial conjunctivitis medication market
  • Global viral conjunctivitis medication market
  • Global allergic conjunctivitis medication market

PART 09: Geographical segmentation

  • Geographical segmentation of global conjunctivitis medication market
  • Conjunctivitis medication market in the Americas
  • Conjunctivitis medication market in EMEA
  • Conjunctivitis medication market in APAC

PART 10: Market drivers

  • Increased exposure to chemicals and pollutants
  • Rising awareness of condition
  • Exploring specific treatment for viral conjunctivitis
  • Tentative approval of pipeline candidates

PART 11: Impact of drivers

PART 12: Market challenges

  • Patent expiry of medication
  • Contentment with existing therapies
  • Adverse effects and limited efficacy of medication

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Strategic alliances and M&A
  • Use of combination therapies
  • Increased R&D

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 16: Key vendor analysis

  • Akorn
  • Alcon
  • Allergan
  • Bausch & Lomb

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Causes of conjunctivitis
  • Exhibit 03: Types of bacterial conjunctivitis
  • Exhibit 04: Types of viral conjunctivitis
  • Exhibit 05: Types of allergic conjunctivitis
  • Exhibit 06: Signs and symptoms of common forms of conjunctivitis
  • Exhibit 07: Medication used for treatment of conjunctivitis
  • Exhibit 08: Global conjunctivitis market: Pipeline portfolio
  • Exhibit 09: Global conjunctivitis market 2014-2019 ($ billions)
  • Exhibit 10: Conjunctivitis market in the US 2014-2019 ($ billions)
  • Exhibit 11: Percentage shares of conjunctivitis medication market in the US and outside the US
  • Exhibit 12: Segmentation of conjunctivitis medication market in US based on condition type 2014
  • Exhibit 13: Bacterial conjunctivitis medication market in the US 2014-2019 ($ millions)
  • Exhibit 14: Viral conjunctivitis medication market in the US 2014-2019 ($ millions)
  • Exhibit 15: Allergic conjunctivitis medication market in the US 2014-2019 ($ millions)
  • Exhibit 16: Conjunctivitis market in US: YoY growth and revenue based on condition type 2014-2019
  • Exhibit 17: Five forces analysis
  • Exhibit 18: Segmentation of global conjunctivitis medication market based on condition type
  • Exhibit 19: Segmentation of global conjunctivitis medication market based on condition type 2014
  • Exhibit 20: Global bacterial conjunctivitis medication market 2014-2019 ($ billions)
  • Exhibit 21: Global viral conjunctivitis medication market 2014-2019 ($ millions)
  • Exhibit 22: Global allergic conjunctivitis medication market 2014-2019 ($ billions)
  • Exhibit 23: Global conjunctivitis medication market: YoY growth and revenue based on condition type 2014-2019
  • Exhibit 24: Geographical segmentation of global conjunctivitis medication market 2014
  • Exhibit 25: Conjunctivitis medication market in the Americas 2014-2019 ($ billions)
  • Exhibit 26: Conjunctivitis medication market in EMEA 2014-2019 ($ millions)
  • Exhibit 27: Conjunctivitis medication market in APAC 2014-2019 ($ millions)
  • Exhibit 28: YoY growth and revenue of global conjunctivitis medication market by region 2014-2019
  • Exhibit 29: Impact of drivers
  • Exhibit 30: Impact of drivers and challenges
  • Exhibit 31: YoY growth and revenue generated from sales of ophthalmic therapeutics 2011-2013 ($ millions)
  • Exhibit 32: Akorn: Key takeaways
  • Exhibit 33: YoY growth and revenue generated from sales of ophthalmic products 2011-2014 ($ billions)
  • Exhibit 34: Percentage share of divisions of Alcon based on revenue 2014
  • Exhibit 35: Alcon: Key takeaways
  • Exhibit 36: Allergan: Key takeaways
  • Exhibit 37: Allergan: Business segmentation 2014 by revenue
  • Exhibit 38: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 39: Allergan: Geographical segmentation by revenue 2014
  • Exhibit 40: Bausch & Lomb: Product categories
Back to Top